Chief Medical Officer Sells Shares in Enliven Therapeutics
Helen Louise Collins, Chief Medical Officer at Enliven Therapeutics (ELVN), sold 5,000 shares of company stock for approximately $199,000 on May 18, 2026. The transaction included an option exercise followed by a sale at around $39.79 per share.
Tickers: $ELVN
Topics: executive activity SEC Form 4 stock sale